Prognostic and predictive biomarkers in breast cancer: Past, present and future

A Nicolini, P Ferrari, MJ Duffy - Seminars in cancer biology, 2018 - Elsevier
Following a diagnosis of breast cancer, the most immediate challenges in patient
management are the determination of prognosis and identification of the most appropriate …

Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers

R Hamam, D Hamam, KA Alsaleh, M Kassem… - Cell death & …, 2017 - nature.com
Effective management of breast cancer depends on early diagnosis and proper monitoring
of patients' response to therapy. However, these goals are difficult to achieve because of the …

Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN/PI3Kγ to promote pancreatic cancer metastasis

X Wang, G Luo, K Zhang, J Cao, C Huang, T Jiang… - Cancer research, 2018 - AACR
Exosomes are emerging as important mediators of the cross-talk between tumor cells and
the microenvironment. However, the mechanisms by which exosomes modulate tumor …

MicroRNA as an important target for anticancer drug development

Z Fu, L Wang, S Li, F Chen, KKW Au-Yeung… - Frontiers in …, 2021 - frontiersin.org
Cancer has become the second greatest cause of death worldwide. Although there are
several different classes of anticancer drugs that are available in clinic, some tough issues …

Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy

E Zhou, Y Li, F Wu, M Guo, J Xu, S Wang, Q Tan… - …, 2021 - thelancet.com
Cancer remains one of the most challenging diseases, as many patients show limited
therapeutic response to treatment. Liquid biopsy is a minimally invasive method that has the …

Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation

J Hausser, AP Syed, B Bilen, M Zavolan - Genome research, 2013 - genome.cshlp.org
Most of what is presently known about how miRNAs regulate gene expression comes from
studies that characterized the regulatory effect of miRNA binding sites located in the 3 …

Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial

I Stevic, V Müller, K Weber, PA Fasching, T Karn… - BMC medicine, 2018 - Springer
Background The focus of this study is to identify particular microRNA (miRNA) signatures in
exosomes derived from plasma of 435 human epidermal growth factor receptor 2 (HER2) …

Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine

B Pasculli, R Barbano, P Parrella - Seminars in cancer biology, 2018 - Elsevier
In the last years, mortality from breast cancer has declined in western countries as a
consequence of a more widespread screening resulting in earlier detection, as well as an …

miRNA dysregulation in breast cancer

L Mulrane, SF McGee, WM Gallagher, DP O'Connor - Cancer research, 2013 - AACR
Abstract miRNAs have emerged, in the last decade, as key players in the carcinogenic
process, with many candidates identified as playing important roles in many aspects of …

Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance

R García-Becerra, N Santos, L Díaz… - International journal of …, 2012 - mdpi.com
Breast cancer is the most frequent malignancy diagnosed in women. Approximately 70% of
breast tumors express the estrogen receptor (ER). Tamoxifen and aromatase inhibitors (AIs) …